Derleme
Yıl 2016,
Cilt: 8 Sayı: 3, 30 - 33, 05.05.2016
Öz
Abstract
"Atypical" pneumonia was described as a distinct and usually mild form of community-acquired pneumonia (CAP) caused by Mycoplasmapneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, Bordetella pertussisand Legionellaspecies. Mycoplasmapneumoniaeis detected in CAP patients most frequently amongschoolaged children from 5 to 15 years of age. Although the infection is generallymild and selflimiting may develop severe or extrapulmonary disease. Further,symptoms and radiologic features are not specific for pneumonia caused by atypical microorganisms. Macrolides are the firstline antibiotics for these infections.
Anahtar Kelimeler
Kaynakça
- Kaynaklar 1.CosentiniR,TarsiaP,BlasiF, Roma E, Allegra L. Community-ac-quired pneumonia: role of atypical organisms.Monaldi Arch ChestDis 2001; 56(6): 527-34. 2.Mani CS, Murray DL. Acute pneumonia and its complications.In: Long SS, Pickering LK, Prober CG, eds.Principles and Prac-tice of Pediatric Infectious Diseases, 4th ed. New York, USA: Els-evier 2012: 235-45. 3.American Academy of Pediatrics. Mycoplasma pneumoniaeand other Mycoplasma species infections. In: Red Book: 2012 Re-port of the Committee on Infectious Diseases, 29th, PickeringLK,ed. American Academy of Pediatrics: Elk Grove Village, IL,2012: 518-23. 4.Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clini-cal characteristics of community-acquired pneumonia in hospi-talized children. Pediatrics 2004;113:701–707. 5.Principi N, Esposito S. Emerging role of Mycoplasma pneumo-niae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001; 1:334. 6.Wang K, Gill P, Perera R, et al. Clinical symptoms and signs forthe diagnosis of Mycoplasma pneumoniae in children and ado-lescents with community-acquired pneumonia. Cochrane Data-base Syst Rev 2012; 10:CD009175. 7.Shah SS. Mycoplasma pneumoniae. In: Long SS, Pickering LK,Prober CG, eds.Principles and Practice of Pediatric InfectiousDiseases, 4th ed. New York, USA: Elsevier, 2012: 993-97. 8.Reittner P, Müller NL, Heyneman L, et al. Mycoplasma pneumo-niae pneumonia: radiographic and high-resolution CT featuresin 28 patients. AJR Am J Roentgenol 2000; 174:37. 9.Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilizati-on of the microbiology laboratory for diagnosis of infectious di-seases: 2013 recommendations by the Infectious Diseases Soci-ety of America (IDSA) and the American Society for Microbio-logy (ASM)(a). Clin Infect Dis 2013; 57:e22. 10.Xu D, Li S, Chen Z, Du L. Detection of Mycoplasma pneumoni-ae in different respiratory specimens. Eur J Pediatr 2011; 170:851. 11.Mulholland S, Gavranich JB, Gillies MB, Chang AB. Antibioticsfor community-acquired lower respiratory tract infections secon-dary to Mycoplasma pneumoniae in children. Cochrane Data-base Syst Rev 2012; 9:CD004875. 12.Rours GI, Hammerschlag MR, Van Doornum GJ, et al. Chlamy-dia trachomatis respiratory infection in Dutch infants. Arch DisChild 2009; 94:705. 13.Hammerschlag MR, Kohlhoff SA. Chlamydia infections. In: Fei-gin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th,Cherry JD, Harrison GJ, Kaplan SL, et al, eds. Philadelphia: Els-evier Saunders, 2014: 2631. 14.Shah SS. Chlamydophila (Chlamydia) pneumoniae. In: Long SS,Pickering LK, Prober CG, eds. Principles and Practice of Pedi-atric Infectious Diseases, 4th ed. New York, USA: Elsevier 2012:881-83. 15.Kumar S, Hammerschlag MR. Acute respiratory infection due toChlamydia pneumoniae: current status of diagnostic methods. ClinInfect Dis 2007;44:568–76. 16.Lee PI, Wu MH, Huang LM, et al. An open, randomized, com-parative study of clarithromycin and erythromycin in the treat-ment of children with community-acquired pneumonia. J Micro-biol Immunol Infect 2008; 41:54
Yıl 2016,
Cilt: 8 Sayı: 3, 30 - 33, 05.05.2016
Öz
Öz
"Atipik" pnömoni, Mycoplasmapneumoniae, Chlamydophila pneumoniae, Chlamy-dophila psittaci, Bordetella pertussis ve Legionellatürlerinin neden olduğu toplum kökenli pnömonilerden farklı ve genellikle daha hafif klinik tablo ile seyreden pnömonilerdir. Mycoplasmapneumoniae özellikle 5 - 15 yaşlarındaki çocuklardaki en sık etkendir. Genellikle hafif ve kendini sınırlayan enfeksiyonlara neden olmakla birlikte,ağır klinik tablolar ya da akciğer dışı enfeksiyonlar da görülebilmektedir. Semptomlar ve radyolojik özellikler atipik mikroorganizmaların neden olduğu pnömoni için özgül değildir. Makrolidler bu enfeksiyonlar için ilk basamak antibiyotiklerdir.
Anahtar Kelimeler
Kaynakça
- Kaynaklar 1.CosentiniR,TarsiaP,BlasiF, Roma E, Allegra L. Community-ac-quired pneumonia: role of atypical organisms.Monaldi Arch ChestDis 2001; 56(6): 527-34. 2.Mani CS, Murray DL. Acute pneumonia and its complications.In: Long SS, Pickering LK, Prober CG, eds.Principles and Prac-tice of Pediatric Infectious Diseases, 4th ed. New York, USA: Els-evier 2012: 235-45. 3.American Academy of Pediatrics. Mycoplasma pneumoniaeand other Mycoplasma species infections. In: Red Book: 2012 Re-port of the Committee on Infectious Diseases, 29th, PickeringLK,ed. American Academy of Pediatrics: Elk Grove Village, IL,2012: 518-23. 4.Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clini-cal characteristics of community-acquired pneumonia in hospi-talized children. Pediatrics 2004;113:701–707. 5.Principi N, Esposito S. Emerging role of Mycoplasma pneumo-niae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001; 1:334. 6.Wang K, Gill P, Perera R, et al. Clinical symptoms and signs forthe diagnosis of Mycoplasma pneumoniae in children and ado-lescents with community-acquired pneumonia. Cochrane Data-base Syst Rev 2012; 10:CD009175. 7.Shah SS. Mycoplasma pneumoniae. In: Long SS, Pickering LK,Prober CG, eds.Principles and Practice of Pediatric InfectiousDiseases, 4th ed. New York, USA: Elsevier, 2012: 993-97. 8.Reittner P, Müller NL, Heyneman L, et al. Mycoplasma pneumo-niae pneumonia: radiographic and high-resolution CT featuresin 28 patients. AJR Am J Roentgenol 2000; 174:37. 9.Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilizati-on of the microbiology laboratory for diagnosis of infectious di-seases: 2013 recommendations by the Infectious Diseases Soci-ety of America (IDSA) and the American Society for Microbio-logy (ASM)(a). Clin Infect Dis 2013; 57:e22. 10.Xu D, Li S, Chen Z, Du L. Detection of Mycoplasma pneumoni-ae in different respiratory specimens. Eur J Pediatr 2011; 170:851. 11.Mulholland S, Gavranich JB, Gillies MB, Chang AB. Antibioticsfor community-acquired lower respiratory tract infections secon-dary to Mycoplasma pneumoniae in children. Cochrane Data-base Syst Rev 2012; 9:CD004875. 12.Rours GI, Hammerschlag MR, Van Doornum GJ, et al. Chlamy-dia trachomatis respiratory infection in Dutch infants. Arch DisChild 2009; 94:705. 13.Hammerschlag MR, Kohlhoff SA. Chlamydia infections. In: Fei-gin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th,Cherry JD, Harrison GJ, Kaplan SL, et al, eds. Philadelphia: Els-evier Saunders, 2014: 2631. 14.Shah SS. Chlamydophila (Chlamydia) pneumoniae. In: Long SS,Pickering LK, Prober CG, eds. Principles and Practice of Pedi-atric Infectious Diseases, 4th ed. New York, USA: Elsevier 2012:881-83. 15.Kumar S, Hammerschlag MR. Acute respiratory infection due toChlamydia pneumoniae: current status of diagnostic methods. ClinInfect Dis 2007;44:568–76. 16.Lee PI, Wu MH, Huang LM, et al. An open, randomized, com-parative study of clarithromycin and erythromycin in the treat-ment of children with community-acquired pneumonia. J Micro-biol Immunol Infect 2008; 41:54
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | makale |
| Yazarlar | |
| Yayımlanma Tarihi | 5 Mayıs 2016 |
| Yayımlandığı Sayı | Yıl 2016 Cilt: 8 Sayı: 3 |
